• Revenue up 31.9% to $212.98 million
• Underlying profit before tax up 40.5% to $157.69 million
• Final dividend of 30 cents per share, up 36.4%

Pro Medicus Limited has reported its financial results for the financial year ended 30 June 2025. The company recorded revenue of $212.98 million, an increase of 31.9% compared to the previous year. Underlying profit before tax, excluding currency gains/losses and fair value movement of other financial assets, was $157.69 million, up 40.5%. Reported profit before tax was $163.31 million, an increase of 40.2%. The company's income tax expense was $48.10 million, resulting in a profit from ordinary activities after tax attributable to members of $115.22 million, up 39.2%. The company has declared a final dividend of 30 cents per share, fully franked, to be paid on 25 September 2025. This represents a 36.4% increase from the previous year's final dividend of 22 cents per share. The company also paid an interim dividend of 25 cents per share, fully franked, on 21 March 2025. The company's net tangible assets per security increased from $1.61 in the previous year to $2.26 in the current year.